Multiple Sclerosis Trial, Recruiting (NCT07466823)

Multiple Sclerosis Trial, Recruiting NCT07466823 Sponsor: Marmara University Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT07466823 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with multiple sclerosis according to the 2024 McDonald criteria
People who are 18 years of age or older
People who have muscle stiffness (spasticity) that has been measured and found to be at a certain level in at least one joint, using a standard rating scale called the Modified Ashworth Scale
People who are able to understand what the study involves and agree in writing to take part
People who do not have significant problems with memory or thinking

Who may not be able to join:

People who have bone, joint, or other nerve or movement conditions that affect how they move, apart from multiple sclerosis
People who have had a Botulinum toxin type A injection (such as Botox used for muscle stiffness) in the past 3 months
People who have previously had surgery to treat muscle stiffness in the upper limbs (arms, hands, or wrists)
People who have bone deformities affecting the upper limbs
People who are unable or unwilling to provide written agreement to take part in the study
People who have problems with memory or thinking (cognitive impairment)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 5346588929

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07466823

Sponsor: Marmara University

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +90 5346588929

More information: https://clinicaltrials.gov/study/NCT07466823

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with multiple sclerosis according to the 2024 McDonald criteria
People who are 18 years of age or older
People who have muscle stiffness (spasticity) that has been measured and found to be at a certain level in at least one joint, using a standard rating scale called the Modified Ashworth Scale
People who are able to understand what the study involves and agree in writing to take part
People who do not have significant problems with memory or thinking

Who may not be able to join:

People who have bone, joint, or other nerve or movement conditions that affect how they move, apart from multiple sclerosis
People who have had a Botulinum toxin type A injection (such as Botox used for muscle stiffness) in the past 3 months
People who have previously had surgery to treat muscle stiffness in the upper limbs (arms, hands, or wrists)
People who have bone deformities affecting the upper limbs
People who are unable or unwilling to provide written agreement to take part in the study
People who have problems with memory or thinking (cognitive impairment)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Marmara University

Registry

ClinicalTrials.gov

Start date

1 January 2026

Est. completion

1 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Classification of Upper and Lower Extremity Spasticity Patterns

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov